{
  "meta": {
    "title": "Anemia_In_Pregnancy_Heart_Disease_In_Pregnancy",
    "url": "https://brainandscalpel.vercel.app/anemia-in-pregnancy-heart-disease-in-pregnancy-66273511.html",
    "scrapedAt": "2025-11-30T11:13:53.819Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">28-30 wk</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">20-22 wk</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">32-34 wk</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">36-38 wk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Peak in cardiac output antenatally occurs at</span></p>",
      "unique_key": "DT1190278",
      "question_audio": null,
      "question_video": null,
      "map_id": 1190278,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Cardiac output</strong> rises by ~30&ndash;50% during pregnancy</li>\r\n<li>The <strong>maximum increase</strong> is observed at <strong>28-30 weeks</strong>, then plateaus</li>\r\n<li><strong>20-22 wk</strong>: Increase ongoing but not at peak (Option B ruled out)</li>\r\n<li><strong>32-34 wk</strong>: Peak already surpassed; levels off (Option C ruled out)</li>\r\n<li><strong>36-38 wk</strong>: May show slight decline due to <strong>vena cava compression</strong> (Option D ruled out)</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>28-30 weeks</strong> is the <strong>peak period</strong> for antenatal cardiac output</li>\r\n<li><strong>Physiologic changes</strong> support increased uterine blood flow</li>\r\n<li><strong>Later stages</strong> may see reduced venous return from mechanical compression</li>\r\n</ul>",
      "correct_choice_id": 1,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">10.0 gm%</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">11.0 gm% </span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">12.0 gm%</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">9.0 gm%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to WHO, anemia in pregnancy is diagnosed, when hemoglobin is less than</span></p>",
      "unique_key": "DT1193519",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193519,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>WHO defines anemia in pregnancy</strong> as hemoglobin <strong>&lt;11.0 gm%</strong></li>\n<li>This cutoff accounts for <strong>hemodilution</strong> due to increased plasma volume</li>\n<li><strong>10.0 gm%</strong>: Below diagnostic threshold, hence incorrect (Option A ruled out)</li>\n<li><strong>12.0 gm%</strong>: Normal range for non-pregnant women; too high for anemia definition (Option C ruled out)</li>\n<li><strong>9.0 gm%</strong>: Indicates <strong>moderate anemia</strong>, not the diagnostic cutoff (Option D ruled out)</li>\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025090677b228df-2b22-4c2d-8a35-2c73f24f2c30.PNG\"><p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>&lt;11.0 gm%</strong> is the WHO cutoff for anemia in pregnancy</li>\n<li>Accounts for <strong>physiologic changes</strong> in blood volume during gestation</li>\n<li>Used globally for <strong>screening and classification</strong></li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum iron</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ferritin</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum transferrin</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum iron binding capacity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests is most sensitive for the detection of iron depletion in pregnancy?</span></p>",
      "unique_key": "DT1193520",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193520,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Serum ferritin</strong> reflects <strong>body iron stores</strong> and is the <strong>earliest and most sensitive indicator</strong> of iron depletion</li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> </strong></p>\r\n<p><strong>Serum iron (Option A):</strong> Fluctuates with diet and inflammation; not reliable for early diagnosis</p>\r\n<p><strong>Serum transferrin (Option C):</strong> Increases in iron deficiency but is nonspecific</p>\r\n<p><strong>Serum iron binding capacity (Option D):</strong> Rises later in deficiency; not as sensitive as ferritin</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Serum ferritin</strong> is the most <strong>sensitive marker</strong> of iron depletion</li>\r\n<li>Used to detect <strong>early-stage iron deficiency</strong></li>\r\n<li>Other iron studies are <strong>less reliable</strong> for early detection</li>\r\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid deficiency</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Malnutrition</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined iron and folic acid deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37 years multipara construction labourer has a blood picture showing hypochromic anisocytosis. This is most likely indicative of:</span></p>",
      "unique_key": "DT1193521",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193521,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Hypochromic anisocytosis</strong> indicates <strong>variation in RBC size</strong> and <strong>decreased hemoglobin content</strong>, consistent with a <strong>mixed deficiency</strong></li>\r\n<li>Common in <strong>economically disadvantaged multiparas</strong> due to <strong>combined nutritional deficits</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Iron deficiency (Option A):</strong> Causes microcytic hypochromic anemia but not significant anisocytosis alone</p>\r\n<p><strong>Folic acid deficiency (Option B):</strong> Produces macrocytosis without hypochromia</p>\r\n<p><strong>Malnutrition (Option C):</strong> Nonspecific term; not a definitive hematologic diagnosis</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Hypochromic anisocytosis</strong> points to <strong>combined deficiencies</strong></li>\r\n<li>Seen in <strong>high-risk populations</strong> like multiparas in poor socioeconomic settings</li>\r\n<li><strong>Mixed anemia patterns</strong> should prompt evaluation for both <strong>iron and folate</strong></li>\r\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 anemia</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid anemia</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron + folic acid anemia</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In pregnancy, which type of anemia is not common in India?</span></p>",
      "unique_key": "DT1193525",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193525,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Vitamin B12 deficiency</strong> is <strong>not commonly seen</strong> in Indian pregnant women</li>\r\n<li><strong>Iron and folic acid deficiencies</strong> are significantly more prevalent due to <strong>dietary insufficiency and increased maternal demands</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> Folic acid anemia (Option B):</strong> Common due to poor intake and increased requirement<br /> <strong>Iron + folic acid anemia (Option C):</strong> Frequently observed in multiparas and undernourished women<br /> <strong>Iron deficiency anemia (Option D):</strong> Most prevalent form of anemia in Indian pregnancy</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Vitamin B12 anemia</strong> is <strong>not a common type</strong> in India</li>\r\n<li><strong>Iron and folate</strong> are the leading deficiencies in pregnant women</li>\r\n<li>Focus of <strong>public health programs</strong> is on iron-folic acid supplementation</li>\r\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency anemia.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Thirty years old G4P3L3 with 32 weeks pregnant with a single live fetus in cephalic presentation, Patient complains of easy fatigability and weakness since the last 3 months which has gradually increased over the last 15 days to an extent that she gets tired of doing household activities. Patient also complains of breathlessness on exertion since the last 15 days. Patient gets breathless on climbing 2 flights of stairs. It is not associated with palpitations or any chest pain. There is no history of pedal edema, sudden onset breathlessness, cough or decreased urine output. There is no history of asthma or chronic cough. There is no history of chronic fever with chills or rigors. There is no history of passage of worms in stool nor blood loss from any site. There is no history of easy bruisability or petechiae. There is no history of yellow discoloration of urine, skin or eyes. She did not take iron folate prophylaxis throughout her pregnancy.<br>She is suspected to be anemic and her blood sample was ordered for examination which showed.<br>Hb 7.4 gm% (12-14 gm%)M<br>Hct 22% (36-44%)<br>MCV 72 fL (80-97 fL)<br>MCH 25 pg (27-33 pg)<br>MCHC 30% (32-36%)<br>Peripheral smear shows microcytic hypochromic RBCs with anisopoikilocytosis Naked eye single tube red cell osmotic fragility test (NESTROFT) is negative. What is the most probable diagnosis:</span></p>",
      "unique_key": "DT1193526",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193526,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Low Hb, Hct, MCV, MCH, and MCHC</strong> indicate <strong>microcytic hypochromic anemia</strong></li>\r\n<li><strong>Peripheral smear</strong> supports the diagnosis with <strong>anisopoikilocytosis</strong></li>\r\n<li><strong>NESTROFT negative</strong> makes thalassemia trait unlikely</li>\r\n<li>Patient has <strong>classic symptoms</strong> of iron deficiency anemia and a <strong>history of no iron prophylaxis</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Thalassemia (Option A):</strong> Ruled out by <strong>negative NESTROFT</strong> and lack of target cells</p>\r\n<p><strong>Megaloblastic anemia (Option C):</strong> Would show <strong>macrocytic RBCs</strong> and possibly hypersegmented neutrophils</p>\r\n<p><strong>Vitamin B12 deficiency anemia (Option D):</strong> Typically <strong>macrocytic</strong>, not microcytic</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Iron deficiency anemia</strong> is the most <strong>common anemia in pregnancy</strong></li>\r\n<li><strong>Negative NESTROFT</strong> helps exclude <strong>thalassemia trait</strong></li>\r\n<li><strong>Microcytic indices</strong> are hallmark for iron deficiency, not B12 or folate deficiency</li>\r\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral iron can be given only if anemia is detected before 20 weeks of pregnancy</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral iron therapy markedly increases the reticulocyte count within 7-14 days</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral therapy is ideal during 30-36 weeks</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood transfusion may be useful in severe anemia beyond 36 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following statements are related to the therapy of iron deficiency anemia except:</span></p>",
      "unique_key": "DT1193527",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193527,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Oral iron</strong> can be administered <strong>anytime during pregnancy</strong> once anemia is diagnosed</li>\r\n<li><strong>Parenteral iron</strong> increases <strong>reticulocyte count within 7-14 days</strong> indicating effective therapy</li>\r\n<li><strong>Parenteral therapy</strong> is ideal during <strong>30-36 weeks</strong> for rapid correction</li>\r\n<li><strong>Blood transfusion</strong> is useful in <strong>severe anemia beyond 36 weeks</strong> or urgent cases</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Oral iron therapy is <strong>not limited to early pregnancy</strong></li>\r\n<li>Parenteral iron and transfusion are reserved for <strong>later pregnancy or severe anemia</strong></li>\r\n<li>Treatment choice depends on <strong>severity and gestational age</strong></li>\r\n</ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Fresh (relatively) blood transfusion</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Routine iron therapy</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Deferoxamine improves pregnancy outcome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are related to the treatment of thalassaemia except:</span></p>",
      "unique_key": "DT1193528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Routine iron therapy</strong> is <strong>not indicated</strong> in thalassemia; patients often develop iron overload due to repeated transfusions.</li>\r\n<li><strong>Fresh blood transfusion</strong> is preferred to reduce iron load and complications</li>\r\n<li><strong>Folic acid</strong> supplementation is necessary due to increased erythropoiesis</li>\r\n<li><strong>Deferoxamine</strong> is an iron chelator that improves outcomes by reducing iron overload in pregnancy</li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> Fresh (relatively) blood transfusion (Option A):</strong> Used to minimize iron overload and alloimmunization<br /> <strong>Folic acid (Option B):</strong> Needed to support increased red cell production<br /> <strong>Deferoxamine improves pregnancy outcome (Option D):</strong> Chelation therapy beneficial in pregnancy with thalassemia</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Iron overload management</strong> is critical in thalassemia; avoid routine iron therapy</li>\r\n<li><strong>Folic acid and transfusions</strong> support effective erythropoiesis</li>\r\n<li><strong>Chelation with deferoxamine</strong> is essential to prevent complications</li>\r\n</ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral 'Pill'</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">IUCD</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Progestin only pill or implant</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are used for contraception in sickle cell anemia except:</span></p>",
      "unique_key": "DT1193529",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193529,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Oral contraceptive pills</strong>, <strong>IUCDs</strong>, and <strong>progestin-only pills or implants</strong> are all <strong>used safely for contraception</strong> in sickle cell anemia patients</li>\r\n<li>No method listed is contraindicated, so <strong>none of the above</strong> is the correct choice</li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> Oral 'Pill' (Option A):</strong> Safe and effective in sickle cell anemia<br /> <strong>IUCD (Option B):</strong> Widely used and safe contraceptive method<br /> <strong>Progestin only pill or implant (Option C):</strong> Preferred in some cases due to lower thrombosis risk</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Multiple contraceptive options are <strong>available and safe</strong> for sickle cell anemia patients</li>\r\n<li>Choice depends on <strong>individual risk factors and pReferences: Williams Obstetrics, 26th edition, Page 731s</strong></li>\r\n<li><strong>No absolute contraindication</strong> among listed methods</li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">1 week</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">3 weeks</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">4 weeks</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">6 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">With oral iron therapy, rise in Hb% can be seen after:</span></p>",
      "unique_key": "DT1193530",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Hemoglobin rises by 0.7-1 gm per week</strong> with oral iron therapy</li>\r\n<li>Significant rise typically seen after <strong>3 weeks</strong> of treatment initiation</li>\r\n<li>Lack of improvement by 3 weeks suggests need for <strong>diagnostic re-evaluation</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> 1 week (Option A):</strong> Too early to see a significant Hb rise<br /> <strong>4 weeks (Option C):</strong> Hb rise starts earlier; 3 weeks is standard timeframe<br /> <strong>6 weeks (Option D):</strong> Hb should have risen well before this</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Hb rise of <strong>3 gm/dL/week or more</strong> indicates response</li>\r\n<li>Assess response by <strong>3 weeks</strong> to guide further management</li>\r\n<li>Delay in improvement warrants investigation of other causes</li>\r\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol use</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Raised MCV in pregnancy can be due to:</span></p>",
      "unique_key": "DT1193531",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193531,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Megaloblastic anemia</strong> causes <strong>macrocytosis</strong> leading to raised MCV</li>\r\n<li><strong>Alcohol use</strong> is a known cause of macrocytosis and increased MCV</li>\r\n<li><strong>Hypothyroidism</strong> can also cause elevated MCV</li>\r\n<li>All these conditions contribute to <strong>raised MCV in pregnancy</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Megaloblastic anemia (Option A):</strong> True but not the only cause</p>\r\n<p><strong>Alcohol use (Option B):</strong> Causes raised MCV</p>\r\n<p><strong>Hypothyroidism (Option C):</strong> Associated with increased MCV</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Raised MCV in pregnancy has <strong>multiple etiologies</strong></li>\r\n<li>Consider <strong>nutritional, toxic, and endocrine causes</strong></li>\r\n<li>Important for <strong>accurate diagnosis and management</strong></li>\r\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">MCV</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">MCH</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">MCHC</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Red cell distribution width</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following parameters will fall the earliest in iron deficiency?</span></p>",
      "unique_key": "DT1193533",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193533,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Among red cell indices, <strong>MCV (mean corpuscular volume)</strong> falls earliest in iron deficiency</li>\r\n<li><strong>Serum ferritin</strong> is the earliest biochemical marker, but among indices, MCV changes first</li>\r\n<li><strong>MCH, MCHC, and RDW</strong> change later in the progression of iron deficiency</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>MCH (Option B):</strong> Falls after MCV changes</p>\r\n<p><strong>MCHC (Option C):</strong> Changes later and less sensitive</p>\r\n<p><strong>Red cell distribution width (Option D):</strong> Increases later due to variation in RBC size</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>MCV decrease</strong> is the earliest red cell index change in iron deficiency</li>\r\n<li><strong>Serum ferritin</strong> is the most sensitive biochemical indicator</li>\r\n<li>Monitoring indices helps in early detection of anemia</li>\r\n</ul>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood volume</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">TIBC</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">MCHC</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">S. ferritin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hematological criteria remains unchanged in pregnancy?</span></p>",
      "unique_key": "DT1193534",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193534,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>MCHC (mean corpuscular hemoglobin concentration)</strong> remains <strong>relatively unchanged</strong> during pregnancy</li>\r\n<li><strong>Blood volume</strong> increases significantly in pregnancy (Option A ruled out)</li>\r\n<li><strong>Total iron binding capacity (TIBC)</strong> increases due to increased transferrin production (Option B ruled out)</li>\r\n<li><strong>Serum ferritin</strong> usually decreases as iron stores are utilized (Option D ruled out)</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>MCHC</strong> is stable and a reliable parameter in pregnancy</li>\r\n<li>Pregnancy causes physiological changes in <strong>blood volume</strong> and <strong>iron metabolism</strong></li>\r\n<li>Understanding these changes is essential for anemia diagnosis</li>\r\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe anemia at 36 weeks</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Moderate anemia at 24-30 weeks</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood loss anemia</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Refractory anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Not an indicator for blood transfusion:</span></p>",
      "unique_key": "DT1193536",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193536,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Moderate anemia at 24-30 weeks</strong> is usually managed medically, not an indication for transfusion</li>\r\n<li><strong>Severe anemia at 36 weeks</strong> requires transfusion due to risks near term</li>\r\n<li><strong>Blood loss anemia</strong> necessitates transfusion to restore volume and oxygen-carrying capacity</li>\r\n<li><strong>Refractory anemia</strong> not responding to treatment is an indication for transfusion</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Blood transfusion is reserved for <strong>severe, refractory, or blood loss anemia</strong></li>\r\n<li>Moderate anemia before third trimester is typically managed with <strong>iron therapy</strong></li>\r\n<li>Correct timing of transfusion is critical for maternal and fetal well-being</li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">1000 mg</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">2000 mg</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">2500 mg</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">3000 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How much iron a patient can tolerate at a time given intravenously?</span></p>",
      "unique_key": "DT1193537",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>Maximum intravenous iron tolerated at a time is <strong>2500 mg</strong> (50 ml &times; 50 mg/ml)</li>\r\n<li>If dose exceeds this, it is split over two days</li>\r\n<li><strong>Iron sorbitol</strong> is preferred for safety over iron dextran</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Maximum safe <strong>IV iron dose is 2500 mg per day</strong></li>\r\n<li>Larger doses require division over multiple days</li>\r\n<li>Choice of preparation affects safety profile</li>\r\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">400 Micrograms</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">4 mg</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">1 mg</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">2 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Dose of folic acid per day for treating megaloblastic anemia in pregnancy:</span></p>",
      "unique_key": "DT1193538",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193538,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>1 mg/day</strong> is the standard dose to <strong>treat megaloblastic anemia</strong> in pregnancy</li>\r\n<li><strong>400 mcg/day</strong> is for <strong>prevention of neural tube defects</strong></li>\r\n<li><strong>4 mg/day</strong> is used in women with <strong>previous history of neural tube defects</strong> or <strong>sickle cell disease.</strong></li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Treatment of megaloblastic anemia requires <strong>1 mg folic acid daily</strong></li>\r\n<li>Higher doses reserved for <strong>high-risk pregnancies</strong></li>\r\n<li>Preventive doses are lower at <strong>400 mcg daily</strong></li>\r\n</ul>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Pre eclampsia</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational diabetes</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">IUGR</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are the complications of anemia except: </span></p>",
      "unique_key": "DT1193539",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193539,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Gestational diabetes</strong> is <strong>not a complication</strong> of anemia</li>\r\n<li>Anemia is linked to <strong>preeclampsia</strong>, <strong>infection</strong>, <strong>IUGR</strong>, and other serious maternal and fetal complications</li>\r\n</ul>\r\n<p><strong>Explanation of other options:<br /> Pre eclampsia (Option A):</strong> Associated with anemia-induced placental insufficiency<br /> <strong>IUGR (Option C):</strong> Due to reduced oxygen delivery to fetus<br /> <strong>Infection (Option D):</strong> Anemia impairs immune response, increasing infection risk</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Anemia causes significant <strong>maternal and fetal morbidity</strong></li>\r\n<li>It contributes to <strong>hypertensive disorders, infections, and poor fetal growth</strong></li>\r\n<li><strong>Gestational diabetes</strong> is unrelated to anemia</li>\r\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron dextran</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron sorbitol</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferric carboxy maltose</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following iron preparations cannot be used intramuscularly?</span></p>",
      "unique_key": "DT1193540",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193540,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Parenteral iron therapy</strong> is indicated in severe anemia cases especially in the last 8-10 weeks of pregnancy, malabsorption syndromes, or dialysis patients</li>\r\n<li><strong>Intramuscular iron preparations include:</strong>\r\n<ul>\r\n<li><strong>Iron dextran</strong></li>\r\n<li><strong>Ferric carboxy maltose</strong></li>\r\n<li><strong>Iron sucrose</strong></li>\r\n</ul>\r\n</li>\r\n<li>Iron sorbitol <strong>cannot be given intramuscularly</strong>; it is administered intravenously only</li>\r\n<li><strong>Administration details for intramuscular iron:</strong>\r\n<ul>\r\n<li>Test dose: 50 mg</li>\r\n<li>Full dose: 100 mg daily or alternate day</li>\r\n<li>Injection site: upper outer quadrant of buttock</li>\r\n<li>Use Z-track method with a thick needle to avoid staining and irritation</li>\r\n</ul>\r\n</li>\r\n<li><strong>Intravenous iron dextran:</strong>\r\n<ul>\r\n<li>Test dose: 0.5 ml</li>\r\n<li>Full dose either as multidose therapy (2 ml/day = 100 mg elemental iron) or single dose diluted in 500 ml saline and infused slowly</li>\r\n</ul>\r\n</li>\r\n<li>If dose &gt; 2500 mg (50 ml &times; 50 mg elemental iron/ml), divide into two infusions on consecutive days</li>\r\n<li>Parenteral iron causes the same Hb rise as oral iron (~0.7-1 gm% per week), main advantage is certainty of dose delivery</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Iron dextran (Option A):</strong> Approved for intramuscular and intravenous use</p>\r\n<p><strong>Ferric carboxy maltose (Option C):</strong> Approved for intramuscular use</p>\r\n<p><strong>None of the above (Option D):</strong> Incorrect, because iron sorbitol cannot be given IM</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Iron sorbitol is contraindicated for intramuscular injection</strong></li>\r\n<li>Parenteral iron is preferred when oral therapy is inadequate or not tolerated</li>\r\n<li>Proper technique and dosing schedules are essential to minimize side effects</li>\r\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">0.5 mg</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">1mg</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">2mg</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">4mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the dose of folic acid in patients with sickle cell diseases?</span></p>",
      "unique_key": "DT1193541",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193541,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In <strong>sickle cell disease during pregnancy</strong>, folic acid supplementation of <strong>4-5 mg daily</strong> is recommended to support <strong>increased red blood cell turnover</strong></li>\r\n<li>Additional management includes:\r\n<ul>\r\n<li>Prophylactic penicillin V 250 mg twice daily</li>\r\n<li>Controversial use of prophylactic blood transfusions to maintain hematocrit &gt;25% and HbS &lt;60%</li>\r\n<li>Hydroxyurea is <strong>not recommended during pregnancy</strong></li>\r\n</ul>\r\n</li>\r\n<li>Regular monitoring of <strong>Hb, hematocrit, platelet count, bilirubin, transaminases, and LDH</strong> is necessary</li>\r\n<li><strong>Vaginal delivery preferred</strong>, with <strong>epidural analgesia</strong> during labor</li>\r\n<li>Postnatal thromboprophylaxis for up to 6 weeks may be indicated</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>High-dose folic acid (4 mg/day)</strong> is essential in sickle cell pregnancy</li>\r\n<li>Management requires <strong>multidisciplinary approach and close monitoring</strong></li>\r\n<li>Avoid <strong>hydroxyurea</strong> during pregnancy due to teratogenicity</li>\r\n</ul>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Exertional dyspnea\t</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Distended neck veins</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic hypotension</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Pedal edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following features indicates the presence of heart disease in pregnancy and which is not seen in normal pregnancy?</span></p>",
      "unique_key": "DT1193543",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193543,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Distended neck veins</strong> indicate <strong>cardiac disease</strong> due to elevated central venous pressure and are <strong>not seen in normal pregnancy</strong></li>\r\n<li><strong>Exertional dyspnea</strong> is common in normal pregnancy due to increased oxygen demand (Option A ruled out)</li>\r\n<li><strong>Systemic hypotension</strong> is not typical in pregnancy but can occur; however, it is less specific (Option C ruled out)</li>\r\n<li><strong>Pedal edema</strong> is frequent in pregnancy due to fluid retention and venous stasis (Option D ruled out)</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Distended neck veins</strong> are a <strong>key sign of heart disease</strong> in pregnancy</li>\r\n<li>Other symptoms like <strong>dyspnea and pedal edema</strong> may be physiological in pregnancy</li>\r\n<li>Careful evaluation needed to distinguish <strong>normal changes from pathology</strong></li>\r\n</ul>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">At term</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate postpartum</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">1st trimester</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">2nd trimester</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Maximum strain of parturient heart occurs during:</span></p>",
      "unique_key": "DT1193544",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193544,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Distended neck veins</strong> indicate <strong>raised central venous pressure</strong>, a sign of <strong>heart disease</strong>, and are <strong>not seen in normal pregnancy</strong></li>\r\n<li><strong>Normal cardiovascular changes in pregnancy</strong> include:\r\n<ul>\r\n<li><strong>Increased blood volume and cardiac output</strong> leading to <strong>physiological exertional dyspnea</strong></li>\r\n<li><strong>Peripheral vasodilation</strong> causes <strong>systemic hypotension</strong> which is not indicative of heart disease</li>\r\n<li><strong>Venous stasis and fluid retention</strong> lead to <strong>pedal edema</strong>, a common physiological finding</li>\r\n</ul>\r\n</li>\r\n<li>These correlations explain why exertional dyspnea, systemic hypotension, and pedal edema are <strong>normal findings</strong>, thus eliminating them as indicators of heart disease</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Exertional dyspnea (Option A):</strong> Due to increased oxygen demand in pregnancy, common and physiological</p>\r\n<p><strong>Systemic hypotension (Option C):</strong> Result of vasodilation during pregnancy; not specific for heart disease</p>\r\n<p><strong>Pedal edema (Option D):</strong> Caused by venous pooling and increased fluid volume; common and physiological</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Distended neck veins</strong> are a clear clinical sign of <strong>cardiac pathology</strong> in pregnancy</li>\r\n<li>Other listed features are <strong>physiological adaptations</strong> and not diagnostic of heart disease</li>\r\n<li>Recognizing these distinctions aids accurate clinical assessment</li>\r\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">IV methergine after delivery</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Prophylactic antibiotic</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">IV furosemide postpartum</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Cut short 2nd stage of labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a pregnant woman with heart disease, all of the following are to be done except:</span></p>",
      "unique_key": "DT1193545",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193545,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>IV methergine</strong> is <strong>contraindicated</strong> in pregnant women with heart disease due to its <strong>vasoconstrictive and hypertensive effects</strong></li>\r\n<li>Other measures are important for managing cardiac patients postpartum:\r\n<ul>\r\n<li><strong>Prophylactic antibiotics</strong> to prevent infections</li>\r\n<li><strong>IV furosemide postpartum</strong> to manage fluid overload and prevent heart failure</li>\r\n<li><strong>Cutting short the second stage of labor</strong> to reduce cardiac stress</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Mnemonic for contraindications of Methergine - TOPER:</strong></p>\r\n<ul>\r\n<li><strong>T</strong>: Toxemia (pre-eclampsia)</li>\r\n<li><strong>O</strong>: Organic heart disease</li>\r\n<li><strong>P</strong>: Pregnancy-induced hypertension</li>\r\n<li><strong>E</strong>: Epilepsy</li>\r\n<li><strong>R</strong>: Renal disease</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Prophylactic antibiotics (Option B):</strong> Prevent infective endocarditis and puerperal infections</p>\r\n<p><strong>IV furosemide postpartum (Option C):</strong> Controls volume overload in cardiac patients</p>\r\n<p><strong>Cut short 2nd stage of labor (Option D):</strong> Minimizes cardiac workload</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Methergine is contraindicated in heart disease</strong> due to risk of hypertensive crisis</li>\r\n<li>Proper postpartum management includes <strong>fluid control and infection prevention</strong></li>\r\n<li><strong>Mnemonic TOPER</strong> aids quick recall of methergine contraindications</li>\r\n</ul>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Eisenmenger syndrome</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">AS</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">MS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following heart diseases is maternal mortality during pregnancy found to be the highest:</span></p>",
      "unique_key": "DT1193546",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193546,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Eisenmenger syndrome</strong> develops due to <strong>secondary pulmonary hypertension</strong> from a left-to-right cardiac shunt reversing to right-to-left, causing <strong>cyanosis</strong></li>\r\n<li>It carries the <strong>highest maternal mortality (~50%)</strong> during pregnancy among heart diseases</li>\r\n<li>Pregnancy is <strong>contraindicated</strong> in Eisenmenger syndrome due to poor prognosis</li>\r\n<li>If diagnosed in the first trimester, <strong>termination of pregnancy is advised</strong></li>\r\n<li>Most common cause of death is <strong>right ventricular failure with cardiogenic shock</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Coarctation of aorta (Option A):</strong> Increased risk but lower mortality than Eisenmenger syndrome</p>\r\n<p><strong>Aortic stenosis (AS) (Option C):</strong> Moderate risk, better prognosis</p>\r\n<p><strong>Mitral stenosis (MS) (Option D):</strong> Common but maternal mortality is lower compared to Eisenmenger syndrome</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Eisenmenger syndrome has the worst maternal prognosis</strong> in pregnancy</li>\r\n<li>Early diagnosis is crucial to counseling and management</li>\r\n<li>Maternal death usually occurs from <strong>right heart failure</strong></li>\r\n</ul>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary pulmonary hypertension</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Wolf-Parkinson-White syndrome</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Eisenmenger syndrome</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan syndrome with dilated aortic root</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Normal pregnancy can be continued in:</span></p>",
      "unique_key": "DT1193547",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193547,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Wolf-Parkinson-White (WPW) syndrome</strong> is usually <strong>compatible with continuation of pregnancy</strong> with proper management</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Primary pulmonary hypertension (Option A):</strong> Pregnancy is contraindicated due to high maternal risk</p>\r\n<p><strong>Eisenmenger syndrome (Option C):</strong> Very high maternal mortality; pregnancy contraindicated</p>\r\n<p><strong>Marfan syndrome with dilated aortic root (Option D):</strong> Risk of aortic rupture; pregnancy often contraindicated if severe dilation</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>WPW syndrome can be safely managed during pregnancy</li>\r\n<li>Other conditions listed pose <strong>significant maternal risks</strong> and generally contraindicate pregnancy</li>\r\n<li>Multidisciplinary care is crucial for management</li>\r\n</ul>",
      "correct_choice_id": 232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral stenosis</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Patent ductus arteriosus</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetralogy of fallot</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most common heart disease associated with pregnancy is:</span></p>",
      "unique_key": "DT1193548",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In <strong>developing countries</strong> like India, the most common heart disease in pregnancy is <strong>rheumatic heart disease</strong></li>\r\n<li>Among rheumatic lesions, <strong>mitral stenosis</strong> accounts for about <strong>80%</strong> of cases, making it the most prevalent</li>\r\n<li><strong>Mitral regurgitation</strong> and <strong>aortic stenosis</strong> follow in frequency</li>\r\n<li>In <strong>developed countries</strong>, <strong>congenital heart diseases</strong> are more common, with <strong>atrial septal defect</strong> being the most frequent</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Mitral regurgitation (Option B):</strong> Common but less than mitral stenosis in rheumatic cases</p>\r\n<p><strong>Patent ductus arteriosus (Option C):</strong> Less common in pregnancy</p>\r\n<p><strong>Tetralogy of Fallot (Option D):</strong> Rare in pregnancy due to cyanotic nature and poor survival</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Mitral stenosis is the predominant heart disease in pregnant women in developing countries</strong></li>\r\n<li>Etiology varies geographically with rheumatic vs congenital causes</li>\r\n<li>Knowledge of regional prevalence aids diagnosis and management</li>\r\n</ul>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Eisenmenger syndrome</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic aneurysm</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic regurgitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> Indications for cesarean section in pregnancy are all except:</span></p>",
      "unique_key": "DT1193550",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193550,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Eisenmenger syndrome</strong> is <strong>not an absolute indication for cesarean section</strong>; vaginal delivery is usually preferred to reduce cardiovascular stress</li>\r\n<li><strong>Aortic stenosis, aortic aneurysm, and aortic regurgitation</strong> may warrant cesarean section to avoid the hemodynamic burden of labor</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Aortic stenosis (Option B):</strong> Cesarean may be indicated to prevent cardiac complications during labor</p>\r\n<p><strong>Aortic aneurysm (Option C):</strong> Cesarean preferred to prevent rupture risk during labor</p>\r\n<p><strong>Aortic regurgitation (Option D):</strong> Severe cases may require cesarean to reduce volume overload</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Delivery mode in cardiac patients is individualized based on lesion severity</li>\r\n<li>Vaginal delivery is favored in <strong>Eisenmenger syndrome</strong> due to high risks with cesarean</li>\r\n</ul>",
      "correct_choice_id": 251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral valve prolapse</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\"> Aortic stenosis</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In heart patient the worst prognosis during pregnancy is seen in:</span></p>",
      "unique_key": "DT1193551",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193551,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Aortic stenosis</strong> carries a <strong>worse prognosis</strong> in pregnancy due to the risk of <strong>left ventricular outflow obstruction, heart failure, and arrhythmias</strong></li>\r\n<li><strong>Mitral regurgitation</strong> usually has a better outcome because of decreased afterload in pregnancy (Option A ruled out)</li>\r\n<li><strong>Mitral valve prolapse</strong> is generally well tolerated (Option B ruled out)</li>\r\n<li><strong>Pulmonary stenosis</strong> tends to be mild and well tolerated in pregnancy (Option D ruled out)</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Severe aortic stenosis</strong> poses a <strong>high risk</strong> during pregnancy</li>\r\n<li>Other valve lesions generally have <strong>better maternal outcomes</strong></li>\r\n<li>Close monitoring and management are essential for cardiac patients in pregnancy</li>\r\n</ul>",
      "correct_choice_id": 263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Spleen</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain\t</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female admitted with septic abortion is diagnosed with tricuspid valve endocarditis. Which organ is most likely to be affected by embolization from the valve vegetation?</span></p>",
      "unique_key": "DT1193552",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193552,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Tricuspid valve endocarditis</strong> involves the <strong>right side of the heart</strong></li>\r\n<li>Emboli from right-sided vegetations enter the <strong>pulmonary circulation</strong>, affecting the <strong>lungs</strong></li>\r\n<li><strong>Liver, spleen, and brain</strong> are commonly affected by emboli from <strong>left-sided endocarditis</strong>, not right-sided</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Liver (Option A):</strong> Left-sided emboli can cause liver infarcts, not typical for tricuspid valve disease</p>\r\n<p><strong>Spleen (Option B):</strong> Splenic emboli occur with left heart involvement</p>\r\n<p><strong>Brain (Option C):</strong> Cerebral emboli arise from left-sided vegetations</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Right-sided endocarditis</strong> leads to <strong>pulmonary septic emboli</strong></li>\r\n<li>Embolic complications depend on the side of heart involved</li>\r\n<li>Important to distinguish right vs left-sided involvement for clinical management</li>\r\n</ul>",
      "correct_choice_id": 274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral opioids</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Spinal anesthesia</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhalational analgesia</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuraxial analgesia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A full-term pregnant woman with known mitral stenosis and mitral regurgitation is planned for normal vaginal delivery. What is the preferred anesthesia technique for labor analgesia in this patient?</span></p>",
      "unique_key": "DT1193553",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193553,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Pain relief is critical</strong> in heart disease patients to prevent <strong>tachycardia</strong> and <strong>cardiac failure</strong></li>\r\n<li><strong>Epidural and spinal anesthesia</strong> (collectively called <strong>neuraxial analgesia</strong>) provide effective, region-specific pain relief during labor</li>\r\n<li>These regional techniques limit systemic stress and maintain <strong>hemodynamic stability</strong></li>\r\n<li><strong>Neuraxial analgesia (epidural)</strong> is the anesthesia of choice in heart disease during pregnancy.</li>\r\n<li>In patients with <strong>heart disease and intracardiac shunts</strong>, <strong>general anesthesia (GA)</strong> is preferred due to risk of paradoxical embolism with neuraxial techniques</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Parenteral opioids (Option A):</strong> Less effective and may cause respiratory depression</p>\r\n<p><strong>Spinal anesthesia (Option B):</strong> Part of neuraxial but single-shot spinal may cause rapid hypotension</p>\r\n<p><strong>Inhalational analgesia (Option C):</strong> Less commonly used, not preferred in heart disease</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Epidural (neuraxial) analgesia</strong> is preferred for labor in heart disease patients</li>\r\n<li><strong>GA preferred</strong> if intracardiac shunts are present</li>\r\n<li>Effective pain control reduces cardiac workload and complications</li>\r\n</ul>",
      "correct_choice_id": 284,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">28 weeks</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">32 weeks</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">36 weeks</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A prosthetic valve patient switches to heparin at which time of pregnancy?\t</span></p>",
      "unique_key": "DT1193555",
      "question_audio": null,
      "question_video": null,
      "map_id": 1193555,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<ul>\r\n<li>In patients with <strong>mechanical prosthetic valves</strong>, anticoagulation management during pregnancy is critical</li>\r\n<li><strong>Warfarin</strong> is used between <strong>12 and 36 weeks</strong> but carries fetal risks (embryopathy, miscarriage, IUGR)</li>\r\n<li><strong>Heparin</strong> (unfractionated) is used:\r\n<ul>\r\n<li><strong>Up to 12 weeks</strong> (to avoid teratogenicity)</li>\r\n<li><strong>From 36 weeks onwards</strong> to reduce bleeding risk during delivery</li>\r\n</ul>\r\n</li>\r\n<li>Heparin is <strong>safe for the fetus</strong> as it does not cross the placenta but is <strong>less effective</strong> than warfarin for thromboprophylaxis</li>\r\n<li>Heparin is continued until <strong>6 hours before delivery</strong> and restarted postpartum (6 hours after vaginal delivery, 24 hours after cesarean)</li>\r\n<li><strong>Warfarin is not contraindicated during breastfeeding</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>28 weeks (Option A) and 32 weeks (Option B):</strong> Too early to switch from warfarin to heparin</p>\r\n<p><strong>Postpartum (Option D):</strong> Heparin is given before delivery as well to manage bleeding risk</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Switch from warfarin to heparin at <strong>36 weeks</strong> to minimize peripartum bleeding</li>\r\n<li>Use <strong>unfractionated heparin</strong> in early and late pregnancy; warfarin in the middle trimester</li>\r\n<li>Careful timing reduces maternal and fetal risks</li>\r\n</ul>",
      "correct_choice_id": 293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}